[go: up one dir, main page]

NL2000351A1 - Estrogeen-modulatoren. - Google Patents

Estrogeen-modulatoren.

Info

Publication number
NL2000351A1
NL2000351A1 NL2000351A NL2000351A NL2000351A1 NL 2000351 A1 NL2000351 A1 NL 2000351A1 NL 2000351 A NL2000351 A NL 2000351A NL 2000351 A NL2000351 A NL 2000351A NL 2000351 A1 NL2000351 A1 NL 2000351A1
Authority
NL
Netherlands
Prior art keywords
estrogen modulators
estrogen
modulators
Prior art date
Application number
NL2000351A
Other languages
English (en)
Other versions
NL2000351C2 (nl
Inventor
Simon Bailey
Stephen Douglas Barret
Larry Don Bratton
Stephen Alan Fakhoury
Sandra Marie Jennings
Lorna Helen Mitchell
Raj Kumar Raheja
Veerabahu Shanmugasundaram
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL2000351A1 publication Critical patent/NL2000351A1/nl
Application granted granted Critical
Publication of NL2000351C2 publication Critical patent/NL2000351C2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/08Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL2000351A 2005-12-22 2006-12-04 Estrogeen-modulatoren. NL2000351C2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75278005P 2005-12-22 2005-12-22
US75278005 2005-12-22
US80523306P 2006-06-20 2006-06-20
US80523306 2006-06-20

Publications (2)

Publication Number Publication Date
NL2000351A1 true NL2000351A1 (nl) 2007-06-25
NL2000351C2 NL2000351C2 (nl) 2007-09-11

Family

ID=38066616

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2000351A NL2000351C2 (nl) 2005-12-22 2006-12-04 Estrogeen-modulatoren.

Country Status (17)

Country Link
US (2) US7470715B2 (nl)
EP (1) EP1966170A2 (nl)
JP (1) JP2009520808A (nl)
KR (1) KR20080073346A (nl)
AP (1) AP2008004481A0 (nl)
AR (1) AR058611A1 (nl)
AU (1) AU2006327877A1 (nl)
BR (1) BRPI0620215A2 (nl)
CA (1) CA2628596A1 (nl)
EA (1) EA200801407A1 (nl)
EC (1) ECSP088533A (nl)
NL (1) NL2000351C2 (nl)
NO (1) NO20082992L (nl)
PE (1) PE20070815A1 (nl)
RS (1) RS20080267A (nl)
UY (1) UY30047A1 (nl)
WO (1) WO2007072164A2 (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013001612A (es) * 2010-08-10 2013-07-05 Abbvie Inc Moduladores de trpv3 novedosos.
CN111938907B (zh) * 2020-08-12 2022-07-01 中国人民解放军陆军军医大学第一附属医院 一种鼻部手术后外敷面罩
GB2608397B (en) * 2021-06-29 2025-04-09 Chaitowitz Ilan Gynecomastia treatment

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US171412A (en) * 1875-12-21 Improvement in buck-boards
US525666A (en) * 1894-09-04 Axel sarnmark
US9799A (en) * 1853-06-21 Simon ikgeksoll
US256210A (en) * 1882-04-11 Bodolphe t
US207927A (en) * 1878-09-10 Improvement in horse hay-rakes
GB1012182A (en) 1963-04-23 1965-12-08 Ass Portland Cement Improvement in the manufacture of hydraulic cement
JPS63108339A (ja) 1986-10-27 1988-05-13 Fuji Photo Film Co Ltd ハロゲン化銀カラ−感光材料の処理方法
GB2201672A (en) 1986-12-18 1988-09-07 Shell Int Research Diphenyl ether compounds
US4933464A (en) 1988-04-25 1990-06-12 W. R. Grace & Co.-Conn. Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles
US4952700A (en) 1988-04-25 1990-08-28 W.R. Grace & Co.-Conn. Preparation of isoxazolines and isoxazoles
JPH089599B2 (ja) 1988-08-02 1996-01-31 三井東圧化学株式会社 ピラゾールカルボン酸類の製造方法
JPH089600B2 (ja) 1988-08-02 1996-01-31 三井東圧化学株式会社 ピラゾールカルボン酸類の製造方法
IT1228288B (it) 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
DE4016049A1 (de) 1990-05-18 1991-11-21 Basf Ag 3-isoxazolylbenzylester, ihre herstellung und ihre verwendung
US5256632A (en) 1990-05-30 1993-10-26 Bayer Aktiengesellschaft Herbicidal sulphonylated carboxamides
DK178590D0 (da) 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
JP3010387B2 (ja) 1991-05-13 2000-02-21 コニカ株式会社 ピラゾール誘導体
JP3454531B2 (ja) 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
DE4137940A1 (de) 1991-11-18 1993-05-19 Basf Ag 3-isoxazolylphenylverbindungen, ihre herstellung und ihre verwendung
AU5891494A (en) 1993-01-29 1994-08-15 Nippon Soda Co., Ltd. Heterocyclic derivative
IT1263751B (it) 1993-02-05 1996-08-27 Mini Ricerca Scient Tecnolog Derivati di esteri arilacetici ad attivita' fungicida
JPH06236057A (ja) 1993-02-10 1994-08-23 Fuji Xerox Co Ltd 電子写真感光体
JPH07304748A (ja) 1993-06-29 1995-11-21 Nissan Chem Ind Ltd アルドキシム誘導体および農園芸用殺菌剤
WO1995011896A1 (en) 1993-10-26 1995-05-04 Nissan Chemical Industries, Ltd. Substituted pyrazole derivative and agrohorticultural fungicide
JP3791015B2 (ja) 1994-03-31 2006-06-28 日産化学工業株式会社 スルホンアミド誘導体の製造方法
JP3329061B2 (ja) 1994-04-19 2002-09-30 三菱化学株式会社 電子写真用感光体
JPH0873436A (ja) 1994-07-06 1996-03-19 Nissan Chem Ind Ltd セミカルバゾン誘導体
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
FR2725988B1 (fr) 1994-10-24 1997-01-24 Roussel Uclaf Nouveaux derives de pyrazolones et pyrazoles acides, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
CN1117080A (zh) 1995-01-11 1996-02-21 刘波 苏云金芽胞杆菌培养基
PL185544B1 (pl) 1995-02-13 2003-05-30 Nowa pochodna podstawionego izoksazolu i środek farmaceutyczny
WO1996033994A1 (en) 1995-04-28 1996-10-31 Nippon Soda Co., Ltd. Amino-substituted derivatives, process for the preparation thereof, and herbicide
CA2224517A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
NZ322674A (en) 1995-10-17 1999-08-30 Searle & Co Method of detecting cyclooxygenase-2
DE69715382T2 (de) 1996-02-13 2003-04-30 G.D. Searle & Co., Chicago Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten
BR9708574A (pt) 1996-04-12 1999-08-03 Searle & Co Derivados benzeno sulfonamida substituídos como pródrogas de inibidores cox-2
JP3399756B2 (ja) 1996-10-22 2003-04-21 三菱製紙株式会社 平版印刷版の処理方法
DK1012144T3 (da) 1997-09-05 2003-07-14 Basf Ag Fremgangsmåde til fremstilling af (hetero)aromatiske hydroxylaminer
CA2372912C (en) 1997-10-14 2008-12-02 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US5972986A (en) 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
JPH11124306A (ja) 1997-10-22 1999-05-11 Nissan Chem Ind Ltd 殺虫・殺ダニ・殺菌剤組成物
US6262098B1 (en) 1998-08-07 2001-07-17 Chiron Corporation Estrogen receptor modulators
AU1199600A (en) 1998-10-02 2000-04-26 Board Of Trustees Of The University Of Illinois, The Estrogen receptor ligands
CA2367895A1 (en) 1999-03-17 2000-09-21 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
AU3253800A (en) 1999-05-14 2000-11-16 Pfizer Products Inc. Combination therapy for the treatment of migraine
US6413965B1 (en) 1999-06-30 2002-07-02 Pfizer Inc. Compositions and treatment for diabetic complications
CO5190678A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia combinada para el tratamiento de la migrana
JP4645871B2 (ja) 1999-09-24 2011-03-09 日本農薬株式会社 イソキサゾリン誘導体及び除草剤並びにその使用方法
CA2390113A1 (en) 1999-12-02 2001-06-07 Maurizio Schwarzenbach Aminoheterocyclylamides as pesticides and antiparasitic agents
EP1276736A2 (en) 2000-04-25 2003-01-22 Pharmacia Corporation Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
JP2001302662A (ja) 2000-04-27 2001-10-31 Nissan Chem Ind Ltd アクリロニトリル化合物
AU2696502A (en) 2000-11-27 2002-06-03 Merck & Co Inc Estrogen receptor modulators
US6693295B2 (en) 2000-12-25 2004-02-17 Fuji Photo Film Co., Ltd. Indole derivative, material for light-emitting device and light-emitting device using the same
US7276523B2 (en) 2001-03-30 2007-10-02 Smithkline Beecham Corporation Aminopyridine derivatives as estrogen receptor modulators
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
EP1270535A3 (de) 2001-06-20 2004-02-18 Clariant GmbH Verfahren zur Herstellung von substituierten aromatischen Verbindungen
US6884814B2 (en) 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
US6960607B2 (en) 2001-12-13 2005-11-01 Wyeth Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
GB0130339D0 (en) 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
JP4399265B2 (ja) 2001-12-21 2010-01-13 ヴァーナリス(ケンブリッジ)リミテッド 3,4−ジアリールピラゾール、および癌の治療におけるそれらの使用
AU2002367426A1 (en) 2001-12-28 2003-07-24 Takeda Chemical Industries, Ltd. Neurotrophic factor production/secretion accelerator
US6803379B2 (en) 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
CA2491132A1 (en) 2002-07-03 2004-01-15 Ortho-Mcneil Pharmaceutical, Inc. Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
US7432284B2 (en) 2002-09-19 2008-10-07 Merck & Co., Inc. Estrogen receptor modulators
WO2004058682A1 (ja) 2002-12-26 2004-07-15 Eisai Co., Ltd. 選択的エストロゲン受容体モジュレーター
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
WO2004073610A2 (en) 2003-02-13 2004-09-02 Merck & Co., Inc. Estrogen receptor modulators
US7183445B2 (en) 2003-05-31 2007-02-27 Janssen Pharmaceutica N.V Cyclohexyl derivatives as selective estrogen receptor modulators
ATE399775T1 (de) 2003-10-08 2008-07-15 Smithkline Beecham Corp Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
US20050256210A1 (en) 2004-05-04 2005-11-17 Roger Olsson Compounds with activity at estrogen receptors

Also Published As

Publication number Publication date
US20070149564A1 (en) 2007-06-28
EP1966170A2 (en) 2008-09-10
BRPI0620215A2 (pt) 2011-11-01
JP2009520808A (ja) 2009-05-28
CA2628596A1 (en) 2007-06-28
EA200801407A1 (ru) 2008-10-30
US7470715B2 (en) 2008-12-30
AP2008004481A0 (en) 2008-06-30
UY30047A1 (es) 2007-07-31
NO20082992L (no) 2008-09-22
KR20080073346A (ko) 2008-08-08
WO2007072164A2 (en) 2007-06-28
RS20080267A (sr) 2009-05-06
ECSP088533A (es) 2008-07-30
AU2006327877A1 (en) 2007-06-28
NL2000351C2 (nl) 2007-09-11
WO2007072164A3 (en) 2007-10-04
PE20070815A1 (es) 2007-08-27
AR058611A1 (es) 2008-02-13
US20090131397A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
NL300935I2 (nl) guselkumab.
FR2909857B1 (fr) Endovalve.
NO20051199D0 (no) Rorhandteringsutstyr.
NL1029457A1 (nl) Androgeenmodulatoren.
FR2882610B1 (fr) Disjoncteur.
EP1915162A4 (en) Modulators
EP1751115A4 (en) THERAMUTEINMODULATOREN
NO20053362D0 (no) Syklofuge.
NL1031752A1 (nl) Androgeenmodulatoren.
NL2000351A1 (nl) Estrogeen-modulatoren.
ES1057865Y (es) Desatascador de desagues.
ES1061247Y (es) Bloque de conexiones intercambiables.
ITCE20060002A1 (it) Patok.
FR2884491B1 (fr) Gouvernail de secours.
ES1059992Y (es) Marco-estuche.
ES1059785Y (es) Caja-asiento.
ES1059608Y (es) Percha-soporte.
ES1060970Y (es) Llavero-monedero.
NO20052882D0 (no) Bolgekraftverk.
NO20052314D0 (no) Thrustertunell.
NO20052152D0 (no) Bolgekraftverk.
NO20051198D0 (no) Nokkelsystem.
ES1061250Y (es) Conjunto garrafa-tapon.
ITMO20050155A1 (it) Beccuccio gobbo.
ITMO20050011U1 (it) Beccuccio gobbo.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20070709

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100701